Timing clarification: Northrop Grumman officially scheduled its second-quarter results for Tuesday, July 21, 2026, before the market opens, with the earnings call at 9:30 a.m. ET that same day—not July 22. This preview uses information available before the release.
The central question is not whether defense demand is strong. It clearly is. The question is whether Northrop can convert that demand into profitable revenue growth and cash flow without additional execution charges or a larger capital-spending burden.
The Street expects approximately:
| Metric | Q2 2026 consensus | Q2 2025 actual | Change |
|---|---|---|---|
| Revenue | $10.8B | $10.35B | +4.3% |
| EPS | $6.83 | $8.15 | -16.2% |
The headline EPS comparison is misleading. Q2 2025 included a $1.04-per-share gain from the divestiture of Northrop’s training-services business. Excluding that benefit, the comparable prior-year figure was about $7.11, implying a more modest decline of roughly 4%.
Investors should focus less on the reported EPS growth rate and more on:
NOC closed July 20 at approximately $524, down about 20% from April 20, immediately before its first-quarter report.
The first-quarter results themselves were reasonably strong, but investors appeared to focus on:
At $524, the shares trade at roughly 19 times the midpoint of 2026 EPS guidance. That is not distressed, but the selloff has reduced the bar for the quarter. A clean report with reaffirmed guidance could be enough for a positive reaction; another program charge or cash-flow concern would likely reinforce the market’s skepticism.
Northrop entered the quarter guiding to:
Management also forecast high-single-digit sequential revenue growth in Q2. From first-quarter revenue of $9.88 billion, that points to approximately $10.7 billion–$10.8 billion, consistent with consensus.
However, if Northrop reports $10.8 billion in Q2 and retains the midpoint of its full-year revenue guidance, it would need to average approximately $11.53 billion of revenue in each of Q3 and Q4. At the consensus Q2 EPS estimate, it would similarly need to average about $7.34 of EPS in each second-half quarter to reach the guidance midpoint.
That makes the earnings call’s discussion of second-half conversion especially important. Investors need evidence that:
A simple guidance reiteration may be accepted, but it will be more credible if management provides concrete support for the second-half cadence.
First-quarter Aeronautics revenue increased 17% to $3.28 billion, driven by B-21, restricted programs and the E-130J TACAMO ramp. Its 9.3% margin benefited from the absence of the prior-year B-21 charge.
The first quarter also included revenue from selling a company-owned B-21 test asset to the Air Force. That accelerated some revenue into Q1, so investors should not automatically extrapolate the 17% growth rate into Q2.
B-21 is approaching 10% of company revenue, and management expects it eventually to exceed 10%. It is therefore too large for even modest estimate changes to be dismissed as program-specific noise.
Best outcome: Continued revenue growth, margins near or above the low-to-mid-9% full-year target and no EAC change.
Primary risk: Another B-21 charge or language suggesting higher early-lot production costs.
Defense Systems posted 10% organic growth in Q1, driven by:
Management subsequently said its weapons business could continue growing in the teens—and potentially into the 20% range—while the overall Defense Systems segment should sustain double-digit growth.
Sentinel accounts for approximately 6%–7% of company revenue and is expected to grow at a low-double-digit rate this year. The program is moving toward:
The year-over-year margin comparison is difficult: Q2 2025 Defense Systems margins were 12.7%, including a $76 million favorable Sentinel EAC adjustment. Investors should not interpret a return toward 10% as deterioration unless the underlying program commentary also weakens.
Mission Systems delivered an unusually strong 15.1% margin in Q1, aided by favorable EAC adjustments. Management believes the business can sustain approximately 15% margins over time as its mix moves toward higher-margin production.
The full-year outlook calls for revenue in the high-$12 billion range and margins in the high-14% range. Because Q1 revenue was only $2.86 billion, the segment needs a meaningful acceleration over the balance of the year.
A quarter featuring 15% margins but soft bookings or revenue would be less encouraging than it initially appears. Investors should distinguish operational improvement from accounting estimate changes.
Space was the weakest business in Q1:
Management has argued that the major NGI and restricted-program comparisons were effectively behind the company after Q1. It expects Space growth to accelerate, supported by:
The annual guide of roughly $11 billion implies a sharp acceleration from the first quarter’s run rate. This makes Space perhaps the most important segment to watch relative to consolidated guidance.
A clean Space quarter could materially improve confidence in the full-year outlook. Continued revenue around the first-quarter level would make the annual guide increasingly difficult to achieve.
Northrop ended Q1 with:
The aggregate backlog is strong, but its composition matters. Q1 backlog was approximately flat with year-end because Mission and Space declines offset growth in Aeronautics.
Investors should watch:
A strong order quarter would support management’s case for accelerating growth in 2027. A weak quarter would not necessarily undermine long-term demand, but it would reinforce concerns about the timing of contract conversion.
First-quarter free cash flow was a use of $1.82 billion, consistent with Northrop’s normal seasonality. Management expects the overwhelming majority of annual cash generation in the second half, particularly Q4.
Northrop maintained its $3.1 billion–$3.5 billion free-cash-flow forecast despite raising 2026 capital spending to approximately $1.85 billion. That is encouraging, but it means the company needs roughly $4.9 billion–$5.3 billion of positive free cash flow over the final three quarters.
The Q2 cash number itself may be less important than management’s confidence in:
A reaffirmed 2026 cash guide would be constructive. Any reduction attributed to working capital or higher capital spending would likely receive an outsized negative reaction.
Given the stock’s decline, this could still produce a positive reaction.
NOC enters the report with strong demand, a large backlog and multiple long-duration growth programs, but also with material execution and capital-intensity concerns.
The most important signal will not be whether EPS beats $6.83 by a few cents. It will be whether management can demonstrate that:
With the shares down materially since the first-quarter report, expectations are more forgiving. A clean quarter and credible guidance reiteration could be sufficient for upside. The clearest downside catalyst would be another program charge or weaker free-cash-flow outlook, particularly if accompanied by additional capital requirements.